Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • biobottom biobottom Feb 12, 2013 12:52 PM Flag

    IMGN Management

    I think I was too critical of Immunogen's management, now especially when I compare it to other biotechs, where all to often the CEO enjoys the prestige and wealth off the backs of shareholders, e.g. CVM, GNBT, and that other one that AF often justly mocks, while they do road shows and send out letters and press releases to fatten the calves for slaughter. At least here at IMGN we have a team that has the courage to invest in the company's future, and the savvy to raise money way before it is needed to fund company owned drug development. So apologies to Mr. Junius who I previously called a self-serving sheister when the stock dropped from 18 from a dilutive funding event.

    Sentiment: Buy

 
IMGN
14.01-0.26(-1.82%)Jul 2 4:00 PMEDT